AS A NEUROSURGEON, I had the pleasure of assisting in the first 5 fenestration operations performed in Valencia, Spain. Having no otologic training and appreciating the difficulties of the endaural approach to the labyrinth, I made investigations which resulted in a new neurosurgical approach to the middle ear and labyrinth. This approach was devised not only for the fenestration operation but also for all procedures in which access to the middle ear and labyrinth is required—labyrinthectomy and others. After a number of experimental attempts on cadavers, the procedure was used on a patient who had otosclerosis but who would be considered a very poor risk for the fenestration operation.
Scophedal (a preparation containing 0.5 mg. of scopolamine hydrobromide, 10 mg. of dihydrohydroxycodeinone hydrochloride and 25 mg. of racephedrine hydrochloride per cubic centimeter), 0.5 cc., is given intramuscularly a half-hour before the operation and the patient's right temporoparietal region shaved
BORDES-VALLS M. NEW NEUROSURGICAL APPROACH FOR TREATMENT OF OTOSCLEROSIS. Arch Otolaryngol. 1950;51(1):96–101. doi:10.1001/archotol.1950.00700020115008
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.